The once-a-day pill from Astellas Pharma uses a new approach, targeting brain connections that help control body temperature to treat moderate-to-severe symptoms, which can include sweating, flushing and chill.
U.S. health regulators on Friday approved use of Veozah, a new type of drug manufactured by Astellas Pharma for women dealing with uncomfortable hot flashes caused by menopause. WASHINGTON — The FDA on Friday gave the green light for use of a new type of drug for women dealing with hot flashes caused by menopause.
The once-a-day pill from Astellas Pharma uses a new approach, targeting brain connections that help control body temperature to treat moderate-to-severe symptoms, which can include sweating, flushing and chill,The drug, to be marketed as Veozah, is the first to target a neuron in the brain that becomes unbalanced as estrogen levels fall,The drug would typically be prescribed for women in their 50s during the menopausal phase estimated to last seven years, according to Astellas Pharma vice...
More than 80% of women experience hot flashes during menopause, the FDA noted, as the body gradually produces lower levels of reproductive hormones between the ages of 45 and 55. “Hot flashes as a result of menopause can be a serious physical burden on women and impact their quality of life,” Dr. Janet Maynard, an official with the F.D.A. Center for Drug Evaluation and Research,. “The introduction of a new molecule to treat moderate to severe menopausal hot flashes will provide an additional safe and effective treatment option for women.”
Hormonal treatments including estrogen and progestin were linked to elevated risks of blood clots and strokes decades ago, butIf you purchase a product or register for an account through one of the links on our site, we may receive compensation.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
1st-of-its-kind drug for severe hot flashes during menopause approved by FDAThe U.S. Food and Drug Administration approved a new pill for moderate to severe hot flashes.
Read more »
FDA approves first-of-its-kind drug to treat hot flashesThe FDA has approved a first-of-its-kind drug to treat moderate to severe hot flashes during menopause.
Read more »
FDA Moves to Curb Misuse of ADHD MedsThe FDA has unveiled fresh measures aimed at tackling persistent worries surrounding the improper use, abuse, addiction, and overdose of prescription stimulants prescribed for ADHD treatment. TwitteRx
Read more »
FDA Clears Renuvion APR Handpiece for Use After LiposuctionThe agency’s update on Wednesday follows three updates on the Renuvion/J-Plasma system in 2022.
Read more »
Sarepta stock soars 30% premarket after FDA panel backs accelerated approval for Duchenne muscular dystrophy therapySarepta Therapeutics Inc.’s stock soared 30% premarket Monday, after a U.S. Food and Drug Administration panel voted 8-6 in favor of accelerated approval for...
Read more »